Chicago Equity Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | $2.1M | Sell |
37,645
-750
| -2% | -$41.8K | 0.21% | 132 |
|
2019
Q4 | $2.47M | Buy |
38,395
+22,370
| +140% | +$1.44M | 0.14% | 214 |
|
2019
Q3 | $813K | Buy |
16,025
+8,710
| +119% | +$442K | 0.04% | 555 |
|
2019
Q2 | $332K | Sell |
7,315
-6,760
| -48% | -$307K | 0.01% | 786 |
|
2019
Q1 | $672K | Sell |
14,075
-6,465
| -31% | -$309K | 0.03% | 607 |
|
2018
Q4 | $1.07M | Buy |
20,540
+5,690
| +38% | +$296K | 0.04% | 478 |
|
2018
Q3 | $922K | Buy |
14,850
+9,120
| +159% | +$566K | 0.03% | 539 |
|
2018
Q2 | $317K | Buy |
+5,730
| New | +$317K | 0.01% | 732 |
|
2018
Q1 | – | Sell |
-3,710
| Closed | -$227K | – | 755 |
|
2017
Q4 | $227K | Hold |
3,710
| – | – | 0.01% | 702 |
|
2017
Q3 | $236K | Hold |
3,710
| – | – | 0.01% | 714 |
|
2017
Q2 | $207K | Buy |
+3,710
| New | +$207K | 0.01% | 728 |
|
2017
Q1 | – | Sell |
-291,725
| Closed | -$17M | – | 721 |
|
2016
Q4 | $17M | Buy |
291,725
+269,210
| +1,196% | +$15.7M | 0.45% | 57 |
|
2016
Q3 | $1.21M | Buy |
22,515
+10,910
| +94% | +$588K | 0.03% | 396 |
|
2016
Q2 | $854K | Sell |
11,605
-25
| -0.2% | -$1.84K | 0.02% | 422 |
|
2016
Q1 | $743K | Buy |
+11,630
| New | +$743K | 0.02% | 402 |
|
2015
Q4 | – | Sell |
-3,725
| Closed | -$221K | – | 593 |
|
2015
Q3 | $221K | Sell |
3,725
-1,960
| -34% | -$116K | 0.01% | 539 |
|
2015
Q2 | $378K | Sell |
5,685
-8,055
| -59% | -$536K | 0.01% | 376 |
|
2015
Q1 | $886K | Sell |
13,740
-75,200
| -85% | -$4.85M | 0.02% | 282 |
|
2014
Q4 | $5.25M | Buy |
88,940
+30,560
| +52% | +$1.8M | 0.14% | 149 |
|
2014
Q3 | $2.99M | Buy |
+58,380
| New | +$2.99M | 0.08% | 189 |
|